Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$775K Buy
25,858
+1,206
+5% +$38.3K 0.01% 729
2025
Q4
$725K Buy
24,652
+4,698
+24% +$124K 0.01% 753
2025
Q3
$521K Buy
19,954
+2,595
+15% +$64.4K 0.01% 905
2025
Q2
$391K Buy
17,359
+1,275
+8% +$26.2K 0.01% 1027
2025
Q1
$336K Buy
16,084
+1,399
+10% +$29.3K 0.01% 1029
2024
Q4
$313K Sell
14,685
-2,345
-14% -$51.4K ﹤0.01% 1163
2024
Q3
$397K Buy
17,030
+2,875
+20% +$67.6K 0.01% 1031
2024
Q2
$314K Buy
+14,155
New +$302K 0.01% 1076

Other funds holding IX

Choreo LLC's IX Position: Q1 2026 in Review

Choreo LLC increased its ORIX (IX) stake by 4.9% in Q1 2026, buying an estimated $38.3K and bringing the position to 25,858 shares worth $775K. The position accounts for 0.01% of the portfolio, ranked #729.

Choreo LLC first reported a position in IX in Q2 2024 and has held it in 8 quarters since. 280 funds tracked by Wall St. Rank hold IX as of Q1 2026.

  • Choreo LLC held 25,858 shares of ORIX worth $775K as of Q1 2026.
  • Choreo LLC bought 1,206 ORIX shares in Q1 2026, an estimated $38.3K.
  • ORIX made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #729 holding.
  • Choreo LLC first reported a position in ORIX in Q2 2024 and has held it in 8 quarters since.
  • 280 funds tracked by Wall St. Rank held ORIX as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.